Miguel Cantu, M.D. Titles and Appointments Assistant Professor Schools Medical School Departments Pathology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Miguel Dario Cantu, MD is a hematopathologist and molecular pathologist at the University of Texas Southwestern where he serves as Assistant Professor of Pathology and Hematopathology Course Director for medical school and pathology residency courses at UTSW. Dr. Cantu is a native of the Rio Grande Valley in South Texas. He graduated summa cum laude from the University of Texas Pan-American with a Bachelor of Science in Biology. He completed his medical training at the University of Texas Health Science Center at Houston’s McGovern Medical School with a scholarly concentration in Molecular and Translational Medicine (2012-2016). He completed an Anatomic and Clinical Pathology Residency at New York Presbyterian – Weill Cornell in New York City (2016-2020) where he served as Assistant Chief Resident and Chief Resident of Anatomic Pathology. He pursued additional fellowship training in Hematopathology at New York Presbyterian—Weill Cornell (2020-2021) followed by a Molecular Genetic Pathology fellowship at the University of Texas Southwestern (2021-2022). Dr. Cantu is board certified by the American Board of Pathology in Anatomic and Clinical Pathology, Hematopathology, and Molecular Genetic Pathology. His clinical research interests include the study of the molecular pathogenesis of myeloid and lymphoid neoplasms with a particular interest in immunodeficiency-associated lymphoproliferative disorders. During his training, Dr. Cantu was a 2021 ASCP 40 Under 40 honoree and received the 2022 Pathologist-in-Training Award from the Society for Hematopathology and the Dr. Janet Caldwell Fellow Research Award for his work studying therapy-related myeloid neoplasms. Education Medical School McGovern Medical School at the University of Texas Health Science Center at Houston (2016) Residency New York Presbyterian Hospital - Weill Cornell Medical Center (2020), Anatomic & Clinical Pathology Fellowship New York Presbyterian Hospital - Weill Cornell Medical Center (2021), Hematopathology Fellowship UT Southwestern Medical Center (2022), Molecular Genetics Publications Featured Publications Correlation of NPM1 immunohistochemistry with mutation subtypes, clinicopathologic variables and molecular testing in AML with NPM1 mutation. Germans SK, Weinberg OK, Chen W, Cantu M, Chen M, Oliver D, Koduru P, Bigham L, Hum Pathol 2026 Feb 171 106073 Grade 3 Pulmonary Lymphomatoid Granulomatosis Diagnosed by Robotic-Assisted Bronchoscopy: A Case Report. Lee M, Hussain AlkhafajiCantu M, Styrvoky K, Wu S, Case Rep Pulmonol 2026 2026 5840915 Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s). Wang SA, Ok CY, Tsai HK, Loayza N, Daneshpajouhnejad P, Seth N, Cantu MD, Bagg A, Tam W, Weinberg O, Barone PD, Geyer JT, Lindsley CR, Montalban-Bravo G, Simon CR, Arber DA, Bueso-Ramos CE, Hsi ED, Foucar K, Orazi A, Patnaik MM, Hasserjian RP, Reichard KK, Haematologica 2025 Dec B/T Mixed Phenotype Acute Leukaemia Harbouring NUP98::BPTF Fusion. Nguyen VT, Han L, Xu J, Cantu M, Fuda F, John S, Slone T, Chen W, EJHaem 2025 Oct 6 5 e70166 Differential diagnosis of multiple myeloma. Cantu MD, Chen W, Semin Diagn Pathol 2025 Aug 150944 Trisomy 8 in De Novo Acute Myeloid Leukemia Lacking MDS-Related Cytogenetics Does Not Significantly Influence Survival. Kwon AJ, Cantu MD, Madanat YF, Hasserjian RP, Koduru P, Wang S, Tang G, Weinberg OK, Int J Lab Hematol 2025 May Investigation of NPM1 mutation frequency in cutaneous blastic plasmacytoid dendritic cell neoplasms. Hamdan H, Siddon A, Ramia de Cap M, Germans S, Cantu MD, Fuda F, Vandergriff T, Aggarwal N, Weinberg OK, Hum Pathol 2025 Apr 158 105766 Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report. Hoff FW, Germans S, Weinberg OK, Collins RH, García R, Chen W, Cantu MD, Chen M, Koduru P, SoRelle J, Madanat YF, Chung SS, Am J Case Rep 2025 Apr 26 e946517 Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort. Kometas ML, Hoff FW, Hyak J, Irizarry-Gatell V, Marinos Velarde A, Jackson C, Anderson J, Kalkan FN, Ramakrishnan Geethakumari P, Alvarenga Thiebaud J, Chen W, Weinberg OK, Cantu MD, Collins RH, Chung SS, Madanat YF, Leuk Lymphoma 2025 Mar 1-9 Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment. Zheng R, Gagan JR, Botten GA, Koduru P, Weinberg OK, Chen M, Cantu MD, Jaso J, Germans S, Luu HS, Han L, Slone TL, Dickerson KE, John S, Madanat YF, Chung S, Collins R, Marinos A, Fuda F, Chen W, Eur J Haematol 2025 Mar Results 1-10 of 28 1 2 3 Next Last
